CPSC to Consider Proposed Rule on Certain OTC Child-Resistant Packaging
The Consumer Product Safety Commission has posted a briefing package and a draft proposed rule that would require child-resistant packaging for any over-the-counter or prescription drug product containing the equivalent of 0.08 milligrams or more of an imidazoline (tetrahydrozoline, naphazoline,…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
oxymetazoline, and xylometazoline) in a single package. Imidazolines are a family of drugs that are vasoconstrictors indicated for nasal congestion and/or ophthalmic irritation. The Commission is scheduled to vote on the draft proposed rule by January 18, 2012.